[en] INTRODUCTION: Low adherence (60-70%) is one of the main problems to face in the management of patients with epilepsy. OBJECTIVES: Evaluate the influencing factors of treatment adherence in a sample of Monographic Epilepsy patients in order to compare the results with a review of the available literature. METHODS: A cross-sectional study in which we evaluate the level of adherence of a 48 patients' sample, diagnosed with Epilepsy and in an ongoing antiepileptic drug (AED) therapy. The adherence was measured with the Morisky-Green test, and the data was analyzed by the Fisher´s exact test. Furthermore, we made a review of the available literature both in PubMed and Cochrane databases. In PubMed, the research was made with "Epilepsy" [Majr] AND "Medication Adherence" [Mesh] AND "Anticonvulsant" [Mesh] and "Epilepsy" [Majr] AND "Medication Adherence" [Mesh] AND "Age Groups" [Mesh]. On the other hand, in Cochrane we searched with "SUDEP" keyword. RESULTS: The adherence in our sample was quite high, of 81.25%. The majority of participants in our study were male (58.33%), 30-60 years old (47.92%), without comorbid psychiatric illness (62.5%), with focal epilepsy (54.17%), with >2 years of disease duration (95.83%), ≤ 2 seizure per month (79.17%) and treated with > 2 AED (60.41%). Even though none of the variables were significantly related with compliance, adherence was lower in male, young patients, without psychiatric comorbidity, focal epilepsy, duration of epilepsy > 2 years, proper illness control and in monotherapy. In relation with the reviewed authors, factors related with non-adherence were younger age, low socioeconomic class, psychiatric comorbidity, generalized epilepsy, high seizure frequency and polytherapy. The main reason for non-adherence was forgetfulness. CONCLUSIONS: To assess the risk factors related with non-adherence is a quite complex procedure. It demands more research in order to reach conclusions to carry out tools which would not just reinforce and encourage treatment compliance among patients but improve illness prognosis and quality of life.

[eu] SARRERA: Epilepsia-kontrakoen kunplimendu baxua (60-70%), Epilepsia daukaten pazienteen tratamenduaren inguruko oinarrizko arazoa da. HELBURUAK: Epilepsia kontsulta monografikotik ateratako pazienteek gaixotasunaren kontrako tratamendua betetzean influentzia daukaten arrisku faktoreak zehaztea, argitaratutako literaturarekin alderaketa egiteko helburuarekin. METODOLOGIA: Epilepsia diagnostiko baieztatua daukaten, eta gaur egun epilepsia-kontrakoekin tratamenduan dauden, 48 paziente lagin baten tratamendu betetze mailan influentzia daukaten arrisku faktoreak ebaluatu ditugun zeharkako azterketa. Kunplimendu maila Morisky-Green testaren bidez neurtu genuen eta, ondoren, lortutako emaitzak Fisher proba zehatzaren bidez aztertu genituen. Horrez gain, PubMed eta Cochrane datu-baseetan eskuragarri zegoen literaturaren berrikuspena egin genuen. Alde batetik, PubMed-en Epilepsy" [Majr] AND "Medication Adherence" [Mesh] AND "Anticonvulsant" [Mesh] eta "Epilepsy" [Majr] AND "Medication Adherence" [Mesh] AND "Age Groups" [Mesh] bilaketa egin zen eta; beste aldetik, Cochrane-n, "SUDEP" hitz gakoa erabili genuen araketa egiteko. EMAITZAK: Ikerketan lortutako tratamendu betetze maila altua izan zen, 81.25%-koa.. Gure pazienteen gehiengoak gizonak ziren (58.33%), 30-60 urte tartean (47.92%), gaixotasun psikiatriko barik (62.5%), epilepsia fokalarekin (54.17%), >2 urteko gaixotasun garapenarekin (95.83%), ≤ 2 hileko krisiekin (79.17%) eta politerapian (60.41%). Alderaketa estatistikoan esangura lortu ez bagenuen ere, kunplimendu emaitzak gizonetan, gazteetan, gaixotasun psikiatrikorik gabeko pazienteetan, epilepsia fokalean, >2 urteko gaixotasunaren garapenarekin, krisien kontrol onarekin eta monoterapian, txarragoak izan ziren. Literatura berrikuspenari dagokionez, urte gutxiago, maila sozioekonomiko baxuagoa edo gaixotasun psikiatriko bat izateak; baita epilepsia orokorra, krisi frekuentzia altua izateak eta politerapian egoteak, betetze maila baxuagoekin erlazionatuta daudela ikusi zen. Tratamendua ez hartzearen oinarrizko arazoa dosia ahaztea izan zen. ONDORIOAK: Tratamenduaren betetze baxuan influentzia daukaten arrisku faktoreak zehaztea prozedura konplexua da. Horrezkero, bere arloaren inguruko ikerketa gehiago egiteko beharra dago; es soilik tratamenduaren kunplimendua sustatzeko eta indartzeko erremientak garatzeko, baita gaixoen pronostikoa eta bizitza kalitatea hobetzeko ere.